Barely Significant
← all excerpts

Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials.

Breast · 2025 · PMC11904565 · PMID 39985843

2
hedged sentences
—
closest p
—
boldest claim

The sentences

In the ABCSG-16 cohort, a notable benefit of extending ET was observed in the high-risk group, even though the result did not reach statistical significance.

also in 111,027 other papers

a numerical trendno p-value reported
The predictive performance of the continuous CTS5 could not be confirmed on the relative scale (interaction p-value 0.47), although there was a numerical trend favoring additional five years of ET in patients with higher CTS5 values.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.